(Q34595255)

English

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study (English)

1 reference

Europe PubMed Central

3 August 2017

bipolar disorder

1 reference

based on heuristic

inferred from title

author name string

Jeff J Guo

1

1 reference

Europe PubMed Central

3 August 2017

Paul E Keck

2

1 reference

Europe PubMed Central

3 August 2017

Patricia K Corey-Lisle

3

1 reference

Europe PubMed Central

3 August 2017

Hong Li

4

1 reference

Europe PubMed Central

3 August 2017

Dongming Jiang

5

1 reference

Europe PubMed Central

3 August 2017

Raymond Jang

6

1 reference

Europe PubMed Central

3 August 2017

Gilbert J L'Italien

7

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

3 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

3 August 2017

27

1 reference

Europe PubMed Central

3 August 2017

1

1 reference

Europe PubMed Central

3 August 2017

27-35

1 reference

Europe PubMed Central

3 August 2017

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Olanzapine-lnduced hyperglycemic nonketonic coma

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Glucose intolerance with atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Olanzapine-induced diabetes in a seven-year-old boy.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Quetiapine-associated hyperglycemia and hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Safety and tolerability of emerging pharmacological treatments for bipolar disorder

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Medicaid policies to contain psychiatric drug costs

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Antidepressant-Associated Mania and Psychosis Resulting in Psychiatric Admissions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Antipsychotic-induced weight gain: bipolar disorder and leptin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Risperidone-associated diabetes mellitus: a pharmacovigilance study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Incident Diabetes Associated With Antipsychotic Use in the United Kingdom General Practice Research Debate

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.1.27

21 January 2018

Identifiers

10.1592/PHCO.27.1.27

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34595255&oldid=1602729940"